Of all the potential pathological mechanisms of MetS, emerging evidence suggests that impaired insulin signaling and increased insulin resistance, as well as elevated status of chronic inflammation, are major risk factors that may induce skin diseases (41–43). Here, INS is linked to metabolic syndrome.